Please select the option that best describes you:

How do you approach a patient with IgG Kappa smoldering myeloma who develops progressive vision loss from optic neuropathy?  

Would you change the threshold for treatment of SMM if there are unexplained symptoms and would you expect the vision to improve if truly related to the monoclonal gammopathy?